Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-14

FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for rosuvastatin calcium (rosuvastatin) from Ascend Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ROSUVASTATIN CALCIUM (rosuvastatin calcium)

Snippet

SUPPL AP for ROSUVASTATIN CALCIUM (ROSUVASTATIN CALCIUM)